For more than 150 years, University of Health Sciences and Pharmacy in St. Louis has provided a world-class education for health care leaders and innovators. Our vibrant community of students, faculty, staff, and alumni
P4 student Rexhian “Reggie” Brisku, B.S. '18, is proof that one person can make a difference by working to eliminate health care disparities that affect the transgender community.
Junior Tasnim Keddo shares how her education and supportive network at University of Health Sciences and Pharmacy in St. Louis is providing her with a foundation for entrance into medical school.
As we commemorate the University’s founding, we reflect upon our history of perseverance, resilience and commitment to building healthier societies.
Tom Burris, Ph.D., Alumni Chair in Pharmaceutical Education and vice president for research and graduate education at UHSP and Kristine Griffett, Ph.D. assistant professor of pharmacology, recently published their research on a nuclear receptor connected to both Alzheimer’s disease and brain cancer.
As winter approaches amid the COVID-19 pandemic, many are feeling the effects of pandemic fatigue. To help combat these feelings, the Counseling Center offers tips for reducing stress and embracing self-care.
When P4 student Matea Markovic was diagnosed with COVID-19 during her Module 2 rotation, she worked closely with Nicole Gattas, Pharm.D., FAPhA, BCPS, director of experiential education and professor of pharmacy practice and her preceptor, Brooke Stanton, Pharm.D. ’15, to stay on track with her studies while in quarantine.
As the semester comes to a close, the Office of Student Affairs shares ways family members can support students as they complete finals remotely.
The newly established esports program at University of Health Sciences and Pharmacy in St. Louis is taking off with the addition of a new head coach, Fernando Paiva, and the completion of a state-of-the-art facility in Jones Hall.
Recently published research from Kristine Griffett, Ph.D., assistant professor of pharmacology, has shed light on the beneficial effects of REV-ERB nuclear receptor activation in the treatment of non-alcoholic steatohepatitis, a condition associated with progressive liver disease.
Explore the archive to read more news and stories about the University community.